A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.

Saved in:
Bibliographic Details
Title: A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphoma.
Authors: Tian XP; Department of Medical Oncology and.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Ma SY; Department of Medical Oncology and.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Young KH; Hematopathology Division, Duke University Medical Center, Duke Cancer Institute, Durham, NC., Ong CK; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.; Oncology Academic Clinical Program (ONCO ACP), Duke-National University of Singapore (NUS) Medical School, Singapore.; Genome Institute of Singapore, Singapore., Liu YH; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China., Li ZH; Department of Oncology, Sun-Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China., Zhai QL; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China., Huang HQ; Department of Medical Oncology and., Lin TY; Department of Medical Oncology and., Li ZM; Department of Medical Oncology and., Xia ZJ; Department of Hematology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Zhong LY; Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China., Rao HL; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Li M; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China., Cai J; Department of Medical Oncology and., Zhang YC; Department of Medical Oncology and., Zhang F; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China., Su N; Department of Medical Oncology and., Li PF; Department of Medical Oncology and., Zhu F; Hematopathology Division, Duke University Medical Center, Duke Cancer Institute, Durham, NC., Xu-Monette ZY; Hematopathology Division, Duke University Medical Center, Duke Cancer Institute, Durham, NC., Wong EKY; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Ha JCH; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Khoo LP; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore., Ai L; Department of Oncology, Sun-Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, People's Republic of China., Cheng RF; Department of Pathology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China., Lim JQ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore.; Oncology Academic Clinical Program (ONCO ACP), Duke-National University of Singapore (NUS) Medical School, Singapore., de Mel S; Department of Haematology-Oncology, National University Cancer Institute of Singapore, National University Health System, Singapore., Ng SB; Department of Pathology, Yong Loo Lin School of Medicine, and.; Cancer Science Institute of Singapore, National University of Singapore, Singapore; and., Lim ST; Oncology Academic Clinical Program (ONCO ACP), Duke-National University of Singapore (NUS) Medical School, Singapore.; Executive Office, National Cancer Centre Singapore, Singapore., Cai QQ; Department of Medical Oncology and.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Source: Blood [Blood] 2021 Aug 12; Vol. 138 (6), pp. 452-463.
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Validation Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1528-0020
DOI:10.1182/blood.2020010637